Independent Second Opinion and Review for Substance Use Assessments in Minnesota

Private-pay, ASAM-informed evaluation conducted by secure telehealth across Minnesota.

A substance use assessment is a clinical document that influences consequential decisions — about treatment commitments, court dispositions, probation conditions, family court findings, professional licensure standing, employer relationships, and insurance coverage. When the conclusions of a prior assessment do not align with the documented clinical picture, or when a substantive decision needs to be made on the basis of a single evaluation, an independent review is appropriate.

Arlucent Assessments provides independent second opinion and review services for adults in Minnesota whose prior substance use assessment has produced findings they wish to have independently reviewed, or who are facing a substantive treatment, legal, or licensure decision and want a structured clinical picture from an evaluator with no operational or financial relationship to the recommended course of action. Evaluations are conducted by secure telehealth and follow the American Society of Addiction Medicine (ASAM) Criteria, Minnesota DHS 245G regulatory standards, and DSM-5/ICD-10 diagnostic conventions.

Independent reviews commissioned through Arlucent Assessments™ produce parallel clinical documents at the same architectural depth as primary assessments. The methodology integrates documentary analysis with an independent clinical interview (Screening), incorporates structured behavioral coherence measurement at the appropriate tier (Tracking), and produces an interpretive synthesis that distinguishes documented evidence, structured clinical analysis, and evaluator conclusions (Analysis) — the same architectural integrity that distinguishes primary Arlucent assessments. 

Independent second opinion and review services are pursued in a range of clinical, legal, and procedural contexts. The most common are summarized below; they are not exhaustive, and the appropriate scope for any particular case is confirmed at intake.

An assessment conducted by a clinician affiliated with a treatment program has produced findings — diagnostic conclusions, severity ratings, or a level-of-care recommendation — that the individual, family, or attorney believes warrant independent review. This is the most common use case. The independent review applies the same ASAM dimensional framework to the documented clinical picture and produces a structured analytic record that can be presented to the court, the licensing authority, the employer, the family system, or the individual themselves as a second clinical reference point.

An assessment conducted as part of a probation, treatment court, or court-ordered process has produced findings whose neutrality is in question — either because the evaluator was structurally affiliated with a recommended service provider, because the assessment was conducted under conditions the individual believes affected its accuracy, or because the resulting documentation does not reflect the clinical picture as the individual or counsel understand it. Independent review in this context provides an alternative clinical document for use in the same regulated decision process.

An individual has been told that treatment is required — at a specified level of care, with a specified duration, at a specified facility — and wishes to obtain an independent clinical picture before committing significant time, financial resources, and personal continuity to that recommendation. In these cases no prior formal assessment is being contested; the individual is seeking a clinically reasoned second reference point prior to a substantial treatment decision. This use case is appropriate where the recommended treatment is private-pay, where insurance authorization depends on documented medical necessity, or where the individual's professional, family, or legal circumstances require deliberate clinical confirmation of the recommended level of care.

A prior chemical use assessment has been entered into a family court proceeding, and one party wishes to introduce an independent review of the assessment's clinical reasoning. Independent review in this context produces a parallel clinical document — not a rebuttal or advocacy document — that the court and the parties can weigh alongside the original.

A licensed professional has been the subject of a substance use assessment conducted in connection with a licensure matter, professional health program referral, or employer-mandated evaluation, and wishes to obtain an independent clinical review. Professional licensure contexts have specific procedural and credentialing considerations that are addressed in detail on the practice's Professional Licensure Evaluation page.

The function of an independent second opinion depends on the independence being structural rather than asserted. An evaluator who provides treatment, who refers to treatment, or who is financially affiliated with treatment providers cannot produce an independent review of another evaluator's treatment recommendation — because the second evaluator's own recommendations are produced under the same structural conditions as the first evaluator's. The result is not a second opinion but a parallel opinion from a structurally similar source.

Arlucent Assessments is structured to function as an independent reference point. The practice provides no treatment, no therapy, no aftercare, no referrals to affiliated programs, and no continuing clinical relationship. There is no organizational benefit to producing any particular finding, recommending any particular level of care, or reaching any particular conclusion about the prior assessment. The evaluating clinician's role concludes with delivery of the written report. This is the structural condition under which the second opinion can function as an independent clinical document in the regulated and consequential decisions for which it is sought.

Independent second opinion and review services are typically conducted at the ACA or ACSA tier. The ASAA tier, which provides regulatory-standard documentation aligned with Minnesota DHS 245G, is appropriate when the second opinion needs to be presented in a regulated context that expects the standard assessment format. Most independent reviews, however, involve diagnostic complexity, contested clinical reasoning, or multi-system considerations that the ACA and ACSA tiers are designed to address.

The Arlucent Clinical Assessment (ACA) is appropriate for second opinions involving a single prior assessment, a clearly defined clinical question, and a single primary use context (court, licensure, family court, or treatment decision). The ACA incorporates narrative formulation and a structured snapshot of The Arlucent Seventh Dimension™, the practice's proprietary analysis of behavioral coherence and value-behavior alignment, which is particularly relevant in cases where the prior assessment's level-of-care recommendation rests on inferences about motivation, readiness, or recovery environment.

The Arlucent Comprehensive Systems Assessment™ (ACSA) is the capstone tier and is appropriate for high-complexity second opinion work — cases involving multiple prior assessments with divergent findings, co-occurring conditions, professional licensure matters, complex custody proceedings, or situations in which the report will be relied upon by multiple decision-making parties (court, licensing authority, employer, family system) simultaneously. The ACSA integrates full ASAM synthesis with a complete multi-domain application of The Arlucent Seventh Dimension™.

Detailed methodology and tier specifications are documented on the Methodology page. Further information on the behavioral coherence framework is available on the Arlucent Seventh Dimension™ page.

Independent second opinion and review services follow the practice's defined intake and evaluation process. The intake questionnaire is the first step — a brief confidential review used to determine whether an independent review is appropriate and within scope for the specific case. Documentation requirements for second opinion work are typically more substantial than for primary assessments: the prior assessment itself, the records underlying it where available, and any subsequent documentation are all relevant to the review.

Following intake review, eligible requests are confirmed, consent materials and scope parameters are provided, and documentation is requested in advance of scheduling. The structured clinical evaluation is conducted by secure telehealth. The written clinical report is prepared and delivered within a timeline confirmed at intake; deadlines tied to court hearings, licensure proceedings, treatment commitments, or other operative deadlines should be communicated at intake so that scope and scheduling can be calibrated accordingly.

Scheduled appointments are confirmed only after payment is received. Reports are delivered as written clinical documents formatted for use in the contexts they are intended to inform.

Evaluations are conducted by Rafael Lewis, M.A., LADC, an independent clinical assessor licensed in Minnesota and the founder of Arlucent Assessments. Mr. Lewis is a doctoral student in counseling psychology at Saint Mary's University of Minnesota and is the developer of The Arlucent Seventh Dimension™ (PFI), the proprietary behavioral coherence framework integrated across the practice's assessment tiers. His clinical and administrative experience includes leadership roles in licensed substance use treatment settings, providing direct working knowledge of the assessment methodologies, documentation conventions, and structural considerations relevant to independent review work.

Additional information on credentialing, professional accountability, and scope of practice is available on the About page.

Individuals, family members, and attorneys evaluating independent review options commonly raise several questions: whether the reviewer is affiliated with any treatment program, what the methodological framework of the review is, what the report will contain and how it will be structured, whether the reviewer will issue conclusions in adversarial or advocacy terms, what the qualifications of the evaluating clinician are, and how the practice handles communication with the parties involved. Arlucent Assessments addresses each of these directly. The practice is structurally unaffiliated with any treatment program. 

The review methodology integrates documentary analysis with an independent clinical interview, applying the ASAM framework to produce parallel clinical findings. Reports are organized to distinguish documented evidence, structured clinical analysis, and evaluator conclusions, and do not adopt advocacy posture. The evaluating clinician's credentials, doctoral training, and clinical leadership background are documented and publicly available. Limited professional communication regarding clarification of review findings is conducted within the bounds of independent evaluation and does not constitute advocacy, expert witness work, or ongoing clinical involvement.

Determining whether an independent second opinion or review is appropriate for your specific circumstances begins with the intake questionnaire. The questionnaire is brief, confidential, and used to confirm that the case is within the practice's scope and to identify the appropriate assessment tier. Documentation requirements, scheduling, and payment are confirmed in writing following intake review.

Scheduled appointments are confirmed only after payment is received.